School of Medicine
Showing 11-20 of 22 Results
-
Emily Clair McClung, MD, FACOG
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. McClung is a fellowship trained, board certified Gynecologic Oncologist with the Stanford Medicine Cancer Center and Clinical Assistant Professor in the Stanford Medicine Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
She graduated from the Icahn School of Medicine at Mount Sinai in New York City and she completed residency in Obstetrics and Gynecology at Stanford Medicine. She then pursued sub-specialty Gynecologic Oncology fellowship at Moffitt Cancer Center and the University of South Florida in Tampa, Florida.
Prior to joining Stanford Health Care, Dr. McClung was an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona Banner University Medical Center in Tucson, Arizona.
Dr. McClung actively contributes to gynecologic cancer research. She has studied prevention of surgical site infections, gene expression prediction of lymph node metastasis in endometrial cancer, treatment resistance in ovarian cancer, and additional topics. She co-authored articles on her findings for peer-reviewed publications such as the International Journal of Gynecologic Cancer, International Journal of Women’s Health, and Gynecologic Oncology Reports.
She authored the chapter on the diagnosis and management of vaginal cancer in the textbook Handbook of Gynecology and has made invited presentations at meetings of the Society of Gynecologic Oncology and other associations. She works to improve patient access to state-of-the-art care as an investigator in cooperative group clinical trials.
She has won multiple teaching awards for her work with medical students and residents. She is passionate about increasing awareness of gynecologic cancer in medical trainees.
Dr. McClung provides comprehensive care with a personalized approach for patients with gynecologic cancer and pre-cancer including surgery, chemotherapy, cancer risk reduction, and palliative care. She has a strong clinical interest in patient safety and quality of life both during and after cancer treatment. -
Amin Milki, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsInfertility
Assisted Reproductive Technologies Microsurgery and Endoscopic Surgery. -
Leah S. Millheiser, MD, FACOG, NCMP
Clinical Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsResearch interest in the role of the central nervous system in female hypoactive sexual desire disorder.
-
Kavita Mishra
Clinical Assistant Professor, Obstetrics & Gynecology
BioDr. Kavita Mishra is a board-certified urogynecologist who specializes in transgender surgery and the treatment of pelvic floor disorders. She has specific training in gender-affirming vaginoplasty, pelvic organ prolapse, and urinary and fecal incontinence. She has expertise in vaginal and minimally invasive reconstructive pelvic surgery, including laparoscopic and robotic approaches.
-
Matteo Amitaba Mole'
Assistant Professor of Obstetrics and Gynecology (Reproductive & Stem Cell Biology)
Current Research and Scholarly InterestsThe research focus of our laboratory is centered on investigating the complex process of human embryo implantation. Due to the limited availability of suitable model systems and inability to directly observe this process in vivo, this has been traditionally referred to as the enigmatic stage of human embryonic development.
The successful implantation of an embryo is crucial for the establishment of a healthy pregnancy. During the transition between the first and second week of gestation, the human embryo must securely implant into the maternal uterus, initiating development of the placenta to receive necessary nutrients and oxygen for its growth until birth.
However, the process of implantation in humans is highly susceptible to failure, with a significant percentage of embryos unable to develop beyond this stage leading to early miscarriages. This clinically observed "implantation barrier" often requires patients to undergo numerous cycles of IVF treatment, with no guarantee of a successful pregnancy outcome.
The primary objective is to increase the understanding of maternal-embryo interactions initiated at implantation, with the goal of developing clinical interventions to address the high incidence of implantation failures underlying pre-clinical miscarriages. -
Brent Monseur, MD, ScM
Instructor, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility
BioBrent Monseur, MD, ScM, FACOG (he/they) is a board certified obstetrician/gynecologist and the founding director of the LGBTQ+ Family Building Clinical Research Program at Stanford University School of Medicine. They are an Instructor in the Department of OBGYN and lead a highly specialized team dedicated to improving reproductive outcomes for sexual and gender minority populations. They completed a fellowship in Reproductive Endocrinology & Infertility at Stanford University after finishing an OB GYN Residency at Thomas Jefferson University. Dr. Monseur received a medical doctorate from the Medical College of Virginia. They trained as a reproductive biologist at the Johns Hopkins Bloomberg School of Public Health where they completed a Master of Science degree. Dr. Monseur received a Bachelor of Science degree in Biochemistry with a concentration in Spanish from the University of Mary Washington.
They have received numerous awards for their work with the LGBTQ+ community including the inaugural Stanford Graduate Medical Education Award for Promoting Health Equity, the Diversity Fellowship Research Award from the American Society for Reproductive Medicine, and an NIH Health Disparities Research Loan Repayment Program award. They serve as a chair of the American Society for Reproductive Medicine’s LGBTQ+ Special Interest Group and have previously served as a board member of two non-profit organizations dedicated to reproductive justice: Medical Students for Choice and Path2Parenthood (now Family Equality).
